BDBM335417 4-[2-({4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-6-methyl-2-oxo-1(2H)-pyridinyl}methyl)-1H-imidazol-5-yl]-2-thiophenecarboxylic acid hydrochloride::US10717738, Example 400::US9732085, 400
SMILES: Cc1cc(cc(=O)n1Cc1ncc([nH]1)-c1csc(c1)C(O)=O)-c1cc(Cl)ccc1-n1cnnn1
InChI Key: InChIKey=OBUASRMCLIKZEW-UHFFFAOYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor XI (Homo sapiens (Human)) | BDBM335417 (4-[2-({4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-6-m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
ONO PHARMACEUTICAL CO., LTD. US Patent | Assay Description Human Factor XIa activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6000, 50 mM HEPES-NaOH (pH7.4) wit... | US Patent US10717738 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor XI (Homo sapiens (Human)) | BDBM335417 (4-[2-({4-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-6-m...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
ONO PHARMACEUTICAL CO., LTD. US Patent | Assay Description Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6... | US Patent US9732085 (2017) BindingDB Entry DOI: 10.7270/Q25X2C2P | |||||||||||
More data for this Ligand-Target Pair |